Day 1
Monday, November 18, 2019 8:30 a.m. - 6:30 p.m.
8:30 - 9:00 AM Registration & Continental Breakfast - Regency Foyer
9:00 - 9:05 AM Welcome Address - Regency Ballroom
David Cassak, Editor-in-Chief, MedTech Strategist
Stephen Levin, Editor-in-Chief, MedTech Strategist
9:05 - 9:35 AM Keynote: The Current State of Medtech and Some Thoughts on the Future
Paul Yock, Founder & Director, Stanford Biodesign
9:35 - 10:15 AM The Biodesign Process: Application and Success in the Real World
Kate Garrett, Managing Partner, Sonder Capital
Uday Kumar, Founder, President & CEO, Element Science, Inc.
Josh Makower, General Partner, New Enterprise Associates
(Moderator) David Cassak, Editor-in-Chief, MedTech Strategist
10:15 - 10:20 AM Sponsor Moderator- Medmarc
10:20 - 10:30 AM Activ Surgical
10:30 - 10:40 AM Veriskin
10:40 - 10:50 AM Tournicare
10:50 - 11:00 AM LightIntegra Technology
11:00 - 11:10 AM CloudCath
11:10 - 11:35 AM Networking Break - Regency Foyer
Speaker Breakout - Grand Peninsula A
11:35 AM - 12:05 PM Spotlight Session: And THAT’S Why We Don’t Talk About Deals During Thanksgiving Dinner! – A Parent’s Guide to Having Deals, From Inception to Maturity
Chris Cleary, VP of Corporate Development, Medtronic
12:05 - 12:50 PM Serial Entrepreneurs: The Good, the Bad and the Ugly Behind Building Successful Companies
Mark Deem, Managing Partner, The Foundry
Amr Salahieh, Co-Founder & CEO, Shifamed
Angela Macfarlane, Managing Member, ForSight Labs; CEO, Voyant Biotherapeutics
(Moderator) Andrew Cleeland, CEO, Fogarty Institute for Innovation
12:50 - 2:00 PM Lunch
2:00 - 2:45 PM Panel: Turning Hiring Obstacles into Opportunities to Build (and Keep) Better Teams
In the never-ending war for talent, medical device companies are straining to find innovative ways to attract top talent… and keep it. This critical panel will explore how today’s competitive job market, access to capital, incoming leadership, timing of hires, inheriting teams, and digital technology – by means of AI, social platforms, and digital media – impact team culture, growth and retention. Join us as we turn hiring obstacles into opportunities.
David Hochman, CEO, Orchestra BioMed, Inc.
Joe Mullings, Founder, Mullings Group
Renee Ryan, CEO, Cala Health
Todd Usen, CEO, Activ Surgical
(Moderator) Kayleen Brown, VP Commercial Development, MedTech Strategist
2:45 - 3:30 PM Keynote: The Current Hospital Scene and What Innovation-Based Start-Ups Need to Know
Jonas Funk, Managing Director & Partner, LEK
(Moderator) David Cassak, Editor-in-Chief, MedTech Strategist
3:30 - 3:35 PM Sponsor Moderator - Olympus Corporation
3:35 - 3:45 PM Integrated Endoscopy, Inc.
3:45 - 3:55 PM Oncodisc
3:55 - 4:05 PM Catheter Precision
4:05 - 4:20 PM Networking Break - Regency Foyer
Speaker Breakout - Grand Peninsula A
4:20 - 4:25 PM Sponsor Moderator - The Mullings Group
4:25 - 4:35 PM Pristine Surgical
4:35 - 4:45 PM Spinex
4:45 - 4:55 PM Embody
4:55 - 5:05 PM ZEPHYRx
5:05 - 5:15 PM Tivic Health Systems
5:15 - 5:30 PM Establishing Patient Access to New Technologies during Clinical Trials: Generating claims data to support the pathway to reimbursement
This program will discuss how sponsor-funded studies are having a negative impact on the reimbursement strategy for new technologies; the importance of claims data generated during a clinical trial to establishing new codes, appropriate payment, and coverage for new technologies upon commercialization; and how a well-managed patient access program can expedite enrollment in a clinical trial and support the reimbursement strategy through claims generation.
Kelli Hallas, Executive VP, Emerson Consultants Inc.
Michael Simon, CEO, PRIA Healthcare
5:30 - 5:45 PM How Medtech Companies Leverage Financial Resources
Chris Coleman, Executive VP & Head of Business Banking, First Republic Bank
5:45 - 7:00 PM Networking Break - Regency Foyer
Speaker Breakout - Grand Peninsula A
Day 2
Tuesday, November 19, 2019 8:00 a.m. - 6:00 p.m.
8:00 - 8:30 AM Registration & Continental Breakfast - Regency Foyer
8:30 - 9:15 AM The Depth and Breadth of Medtech M&A in a Global Market
Noam Krantz, Vice President, Business Development, Ethicon
Christos Monovoukas, VP, Global M&A Leader / Business Development, Olympus
Justin Noznesky, Senior VP, Marketing and Business Development, AtriCure
Stephen Sweeny, Senior Director, Corporate Development, Medtronic
(Moderator) Stephen Levin, Editor-in-Chief, MedTech Strategist
9:15 - 9:20 AM Sponsor Moderator- genae
9:20 - 9:30 AM Digital Transformation in Clinical Trials
Aly Talen, Co-Founder & Senior VP Business Development, genae
9:30 - 9:40 AM Nephrodite
9:40 - 9:50 AM Cytex Therapeutics
9:50 - 10:00 AM WISE Srl
10:00 - 10:10 AM Fibralign Corporation
10:10 - 10:20 AM Fischer Imaging
10:20 - 10:30 AM Pillo Health
10:30 - 10:55 AM Networking Break - Regency Foyer
Speaker Breakout - Grand Peninsula A
10:55 - 11:00 AM Knobbe Martens
11:00 AM - 12:00 PM Patent Law Update for Medical Device Companies 2019
Paul Conover, Partner, Knobbe Martens
Curtis Huffmire, Partner, Knobbe Martens
12:00 - 1:15 PM Lunch - The Grove
1:15 - 1:20 PM Sponsor Moderator - Intertek
1:20 - 1:30 PM Verndari
1:30 - 1:40 PM Irisvision
1:40 - 1:50 PM Centese
1:50 - 2:00 PM Diality
2:00 - 2:10 PM Prenosis, Inc.
2:10 - 2:20 PM Navigation Sciences
2:20 - 2:35 PM Networking Break - Regency Foyer
Speaker Breakout - Grand Peninsula A
2:35 - 2:40 PM Moderator - NAMSA
2:40 - 3:10 PM Keynote: Winning is the Only Option
Duke Rohlen, Founder & CEO, Ajax Health
3:10 - 3:55 PM Raising Capital - Turning Off the Spigot - Mistakes VCs See When Companies Pitch Them
Mike Carusi, General Partner, Lightstone Ventures
Steven Hochberg, Partner, Deerfield Management
(Moderator) Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati
3:55 - 4:00 PM Sponsor Moderator - Hantel Technologies
4:00 - 4:10 PM Promaxo
4:10 - 4:20 PM NIDO
4:20 - 4:30 PM 3VO Medical
4:30 - 4:40 PM Optina Diagnostics
4:40 - 4:50 PM Carmell Therapeutics
4:50 - 5:00 PM Stroma Medical
5:00 - 6:00 PM Closing Reception
